Generic Saxenda® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the ...

Teva Pharmaceuticals has received FDA approval and has launched a generic version of Saxenda (liraglutide), which is approved to treat adults and adolescents 12 to 17 years of age who are obese or ...

The NHS have rolled out an exciting new weight loss jab — Saxenda — in Boots stores nationwide. But how does the injection actually work and is it really that safe?

You may have seen a weight-loss injection at Boots and Lloyds pharmacies across the UK doing the rounds on TikTok recently. The medication, called Saxenda, became available with a quick online ...

Teva Pharmaceuticals announced in late August 2025 that it received FDA approval and commenced the U.S. launch of its generic version of Saxenda® (liraglutide injection), which had annual sales of ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best strong buy growth stocks to buy now. On August 28, Teva ...

Saxenda sales came in at about 3,800 last week. Saxenda recovered from holiday dip and delivered higher numbers than prior to holiday.

The biggest difference between Saxenda and the branded obesity pills is not whether it is an injection, not how safe it is, and not how effective it is.

Read more: Doctors warn against Saxenda, Ozempic ‘quick fix’ diabetes injections for weight loss UK probes suicide risks linked to Novo’s Ozempic, weight-loss drug Saxenda ...

Generic Saxenda® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the U.S. market.This approval and launch add to Teva’s continu ...